A series of clinical trials using MDMA and psilocybin mushrooms represent a resurrection of promising research abandoned in the 1960s.
Four Veterans Affairs clinicians, frustrated with existing treatments for addiction and PTSD, have turned to drugs the government still deems illegal.
Most travelers descending on Zihuatanejo are unaware of the resort city’s storied past with the apostle of psychedelic drugs, and his experiments in consciousness expansion.
The chemical derived from psychedelic mushrooms helped alleviate symptoms of depression and generated detectable neural responses that lasted weeks.
Several psychedelic drugs are touted as effective treatments for drug and alcohol abuse. But psilocybin combined with therapy is emerging as the most effective.
Even with cause for concern, retreats in countries like Costa Rica and Jamaica, as well as in the United States, have been popping up for more than a decade.
Lawmakers find it hard to “just say no” to combat veterans seeking support for drug decriminalization efforts gaining traction around the country.
The war on drugs is ending. Now we have to figure out what the peace looks like.
Psilocybin and MDMA are poised to be the hottest new therapeutics since Prozac. Universities want in, and so does Wall Street. But some researchers are wary about this going too far.